BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 23566225)

  • 21. Synthesis and biological activity of 2-methyl-20-epi analogues of 1 alpha,25-dihydroxyvitamin D3.
    Fujishima T; Liu Z; Miura D; Chokki M; Ishizuka S; Konno K; Takayama H
    Bioorg Med Chem Lett; 1998 Aug; 8(16):2145-8. PubMed ID: 9873502
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hydrogen/deuterium exchange reveals distinct agonist/partial agonist receptor dynamics within vitamin D receptor/retinoid X receptor heterodimer.
    Zhang J; Chalmers MJ; Stayrook KR; Burris LL; Garcia-Ordonez RD; Pascal BD; Burris TP; Dodge JA; Griffin PR
    Structure; 2010 Oct; 18(10):1332-41. PubMed ID: 20947021
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synthesis of Gemini analogs of 19-norcalcitriol and their platinum(II) complexes.
    Brzeminski P; Fabisiak A; Berkowska K; Rárová L; Marcinkowska E; Sicinski RR
    Bioorg Chem; 2020 Jul; 100():103883. PubMed ID: 32361296
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Synthesis and biological activity of 22-iodo- and (E)-20(22)-dehydro analogues of 1alpha,25-dihydroxyvitamin D3.
    Sicinski RR; DeLuca HF
    Bioorg Med Chem; 1999 Dec; 7(12):2877-89. PubMed ID: 10658592
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Novel 1alpha,25-dihydroxyvitamin D3 analogues with the side chain at C12.
    González-Avión XC; Mouriño A; Rochel N; Moras D
    J Med Chem; 2006 Mar; 49(5):1509-16. PubMed ID: 16509569
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Design, synthesis and biological properties of seco-d-ring modified 1α,25-dihydroxyvitamin D
    Szybinski M; Sektas K; Sicinski RR; Plum LA; Frelek J; DeLuca HF
    J Steroid Biochem Mol Biol; 2017 Jul; 171():144-154. PubMed ID: 28285018
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Adaptability of the Vitamin D nuclear receptor to the synthetic ligand Gemini: remodelling the LBP with one side chain rotation.
    Ciesielski F; Rochel N; Moras D
    J Steroid Biochem Mol Biol; 2007 Mar; 103(3-5):235-42. PubMed ID: 17218092
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Structure-activity relationship study of vitamin D analogs with oxolane group in their side chain.
    Belorusova AY; Martínez A; Gándara Z; Gómez G; Fall Y; Rochel N
    Eur J Med Chem; 2017 Jul; 134():86-96. PubMed ID: 28399453
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Efficient and versatile synthesis of novel 2alpha-substituted 1alpha,25-dihydroxyvitamin D(3) analogues and their docking to vitamin D receptors.
    Suhara Y; Nihei KI; Kurihara M; Kittaka A; Yamaguchi K; Fujishima T; Konno K; Miyata N; Takayama H
    J Org Chem; 2001 Dec; 66(26):8760-71. PubMed ID: 11749604
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Synthesis and Biological Activity of 2-Methylene Analogues of Calcitriol and Related Compounds.
    Sibilska IK; Szybinski M; Sicinski RR; Plum LA; DeLuca HF
    J Med Chem; 2015 Dec; 58(24):9653-62. PubMed ID: 26574921
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Structural evaluation of the agonistic action of a vitamin D analog with two side chains binding to the nuclear vitamin D receptor.
    Väisänen S; Peräkylä M; Kärkkäinen JI; Uskokovic MR; Carlberg C
    Mol Pharmacol; 2003 Jun; 63(6):1230-7. PubMed ID: 12761332
    [TBL] [Abstract][Full Text] [Related]  

  • 32. New derivatives of 1alpha,25-dihydroxy-19-norvitamin D3 with two substituents at C-2: synthesis and biological activity.
    Shimizu M; Iwasaki Y; Shimazaki M; Amano Y; Yamamoto K; Reischl W; Yamada S
    Bioorg Med Chem Lett; 2005 Mar; 15(5):1451-5. PubMed ID: 15713405
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Synthesis and biological activity of 22-oxa CD-ring modified analogues of 1alpha,25-dihydroxyvitamin D3: cis-perhydrindane CE-ring analogues.
    Demin S; Van Haver D; Vandewalle M; De Clercq PJ; Bouillon R; Verstuyf A
    Bioorg Med Chem Lett; 2004 Aug; 14(15):3885-8. PubMed ID: 15225690
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Practical synthesis and evaluation of the biological activities of 1alpha,25-dihydroxyvitamin D3 antagonists, 1alpha,25-dihydroxyvitamin D3-26,23-lactams. Designed on the basis of the helix 12-folding inhibition hypothesis.
    Nakano Y; Kato Y; Imai K; Ochiai E; Namekawa J; Ishizuka S; Takenouchi K; Tanatani A; Hashimoto Y; Nagasawa K
    J Med Chem; 2006 Apr; 49(8):2398-406. PubMed ID: 16610783
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Calcitriol derivatives with two different side chains at C-20. 24-hydroxy derivatives as metabolic products and molecular probes for VDR exploration.
    Maehr H; Uskokovic MR; Reddy GS; Adorini L
    J Steroid Biochem Mol Biol; 2004 May; 89-90(1-5):35-8. PubMed ID: 15225743
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Novel vitamin D(3) analog, 21-(3-methyl-3-hydroxy-butyl)-19-nor D(3), that modulates cell growth, differentiation, apoptosis, cell cycle, and induction of PTEN in leukemic cells.
    Hisatake J; O'Kelly J; Uskokovic MR; Tomoyasu S; Koeffler HP
    Blood; 2001 Apr; 97(8):2427-33. PubMed ID: 11290607
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Low-calcemic, efficacious, 1alpha,25-dihydroxyvitamin D3 analog QW-1624F2-2: calcemic dose-response determination, preclinical genotoxicity testing, and revision of A-ring stereochemistry.
    Posner GH; Jeon HB; Sarjeant A; Riccio ES; Doppalapudi RS; Kapetanovic IM; Saha U; Dolan P; Kensler TW
    Steroids; 2004; 69(11-12):757-62. PubMed ID: 15579327
    [TBL] [Abstract][Full Text] [Related]  

  • 38. 2-Ethyl and 2-ethylidene analogues of 1alpha,25-dihydroxy-19-norvitamin D(3): synthesis, conformational analysis, biological activities, and docking to the modeled rVDR ligand binding domain.
    Sicinski RR; Rotkiewicz P; Kolinski A; Sicinska W; Prahl JM; Smith CM; DeLuca HF
    J Med Chem; 2002 Aug; 45(16):3366-80. PubMed ID: 12139448
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Synthesis, structure, and biological activity of des-side chain analogues of 1α,25-dihydroxyvitamin D3 with substituents at C18.
    Verlinden L; Verstuyf A; Eelen G; Bouillon R; Ordóñez-Morán P; Larriba MJ; Muñoz A; Rochel N; Sato Y; Moras D; Maestro M; Seoane S; Dominguez F; Eduardo-Canosa S; Nicoletti D; Moman E; Mouriño A
    ChemMedChem; 2011 May; 6(5):788-93. PubMed ID: 21520419
    [TBL] [Abstract][Full Text] [Related]  

  • 40. New 1alpha,25-dihydroxy-19-norvitamin D3 compounds of high biological activity: synthesis and biological evaluation of 2-hydroxymethyl, 2-methyl, and 2-methylene analogues.
    Sicinski RR; Prahl JM; Smith CM; DeLuca HF
    J Med Chem; 1998 Nov; 41(23):4662-74. PubMed ID: 9804706
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.